Cosmos Health Inc (COSM)

$0.31 +0.00 (0.13%)
Market Cap 16.06M
Revenue (ttm) 65.27M
Net Income (ttm) -19.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 4.15
Profit Margin -29.34%
Debt to Equity Ratio 0.58
Volume 1,234,900
Avg Vol 928,046
Day's Range N/A - N/A
Shares Out 52.33M
Stochastic %K 10%
Beta 5.00
Analysts Strong Buy
Price Target $4.50

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvas...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
141 West Jackson Boulevard, Suite 4236, Chicago, United States
Stopcryin
Stopcryin May. 13 at 11:59 AM
$COSM $0.32 ... here comes the $1 needed to get back in compliance with Nasdaq.
0 · Reply
walfofwallstreet
walfofwallstreet May. 13 at 11:12 AM
$COSM 👇🗞️💎👀👀👀👀👀🐺 Withdraws Registration Offering
0 · Reply
Stopcryin
Stopcryin May. 13 at 10:33 AM
$COSM ... or not! 😬😬
0 · Reply
Stopcryin
Stopcryin May. 13 at 10:32 AM
$COSM This is not aging well ... they never do 😉
0 · Reply
Stopcryin
Stopcryin May. 13 at 10:30 AM
$COSM This didn't age so well 😆
0 · Reply
Skoufa
Skoufa May. 13 at 8:15 AM
$COSM 15x from here
0 · Reply
Skoufa
Skoufa May. 13 at 8:15 AM
$COSM
0 · Reply
SuperShlongCapital
SuperShlongCapital May. 13 at 3:28 AM
$COSM This will likely cross $2 within 1 week. Tiny tiny float.
0 · Reply
ace6th
ace6th May. 13 at 1:35 AM
$COSM looking for .60s short term
0 · Reply
ace6th
ace6th May. 13 at 1:33 AM
$COSM Extremely oversold, Eyes on it! Ignore the Nay Sayers
0 · Reply
Latest News on COSM
Cosmos Health announces withdrawal of registration statement on Form S-1

2026-05-12T18:46:06.000Z - 18 hours ago

Cosmos Health announces withdrawal of registration statement on Form S-1

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 12, 2026, 10:15 AM EDT - 22 hours ago

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 11, 2026, 2:25 PM EDT - 1 day ago

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 8, 2026, 11:25 AM EDT - 4 days ago

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

Cosmos Health sees over $2.5M incremental annual revenue from Cur18 in U.S.

2026-04-30T17:37:57.000Z - 12 days ago

Cosmos Health sees over $2.5M incremental annual revenue from Cur18 in U.S.

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Apr 30, 2026, 12:50 PM EDT - 12 days ago

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Apr 21, 2026, 12:50 PM EDT - 21 days ago

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Apr 20, 2026, 10:55 AM EDT - 22 days ago

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Cosmos Health announces planned U.S. market launch of Cur18b

2026-04-17T18:05:11.000Z - 25 days ago

Cosmos Health announces planned U.S. market launch of Cur18b

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Apr 17, 2026, 2:00 PM EDT - 25 days ago

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Apr 16, 2026, 3:15 PM EDT - 26 days ago

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Cosmos Health reports FY25 adjusted EPS (12c) vs. (65c) last year

2026-04-15T13:37:21.000Z - 27 days ago

Cosmos Health reports FY25 adjusted EPS (12c) vs. (65c) last year

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Apr 15, 2026, 9:25 AM EDT - 27 days ago

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

Apr 13, 2026, 12:50 PM EDT - 4 weeks ago

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

Cosmos Health reports ‘no impact’ from Iran, MiddleEast conflict

2026-04-10T13:50:15.000Z - 4 weeks ago

Cosmos Health reports ‘no impact’ from Iran, MiddleEast conflict

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

Apr 10, 2026, 9:40 AM EDT - 4 weeks ago

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

Cosmos Health announces planned Q2 U.S. launch of Liv18

2026-04-08T15:16:18.000Z - 4 weeks ago

Cosmos Health announces planned Q2 U.S. launch of Liv18

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

Apr 8, 2026, 11:10 AM EDT - 4 weeks ago

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

Apr 1, 2026, 11:42 AM EDT - 5 weeks ago

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

Cosmos Health says to issue updated guidance following FY25 results

2026-03-19T16:51:17.000Z - 7 weeks ago

Cosmos Health says to issue updated guidance following FY25 results

Cosmos Health says evaluating potential monetization options

2026-03-19T16:50:48.000Z - 7 weeks ago

Cosmos Health says evaluating potential monetization options

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

Mar 19, 2026, 12:45 PM EDT - 7 weeks ago

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000

Mar 11, 2026, 1:45 PM EDT - 2 months ago

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000

Cosmos Health enters LOI to acquire pharmacy distribution network

2026-03-10T13:06:10.000Z - 2 months ago

Cosmos Health enters LOI to acquire pharmacy distribution network

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

Mar 10, 2026, 9:00 AM EDT - 2 months ago

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

Feb 24, 2026, 12:30 PM EST - 2 months ago

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value

Feb 19, 2026, 11:30 AM EST - 2 months ago

Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value

Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer

Feb 18, 2026, 1:45 PM EST - 2 months ago

Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer

Cosmos Health announces C-Scrub availability at Tesco

2026-02-18T15:20:19.000Z - 2 months ago

Cosmos Health announces C-Scrub availability at Tesco

Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer

Feb 18, 2026, 10:17 AM EST - 2 months ago

Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026

Feb 17, 2026, 11:25 AM EST - 3 months ago

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026

Cosmos Health purchases $500,000 of bitcoin

2026-02-11T17:15:23.000Z - 3 months ago

Cosmos Health purchases $500,000 of bitcoin

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

Feb 11, 2026, 12:10 PM EST - 3 months ago

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies

Cosmos Health sees expansion supporting $40M in additional annual revenue

2026-01-20T15:50:20.000Z - 4 months ago

Cosmos Health sees expansion supporting $40M in additional annual revenue

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

Jan 20, 2026, 10:45 AM EST - 4 months ago

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue

Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research

Jan 14, 2026, 11:25 AM EST - 4 months ago

Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research

Cosmos Health enters manufacturing agreement with Libytec

2026-01-05T14:45:09.000Z - 4 months ago

Cosmos Health enters manufacturing agreement with Libytec

Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units

Jan 5, 2026, 9:30 AM EST - 4 months ago

Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

Dec 24, 2025, 9:00 AM EST - 4 months ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

Cosmos Health is Forcing the Market to Reframe the Conversation

Dec 19, 2025, 9:00 AM EST - 5 months ago

Cosmos Health is Forcing the Market to Reframe the Conversation

Cosmos Health enters long-term partnership with Prime Ledger

2025-12-03T17:25:35.000Z - 5 months ago

Cosmos Health enters long-term partnership with Prime Ledger

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Dec 3, 2025, 12:20 PM EST - 5 months ago

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Dec 2, 2025, 12:15 PM EST - 5 months ago

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Cosmos Health reports Q3 adjusted EPS (2c) vs. (34c) last year

2025-11-17T14:20:09.000Z - 6 months ago

Cosmos Health reports Q3 adjusted EPS (2c) vs. (34c) last year

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Nov 17, 2025, 9:15 AM EST - 6 months ago

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Cosmos Health files $200M mixed securities shelf

2025-11-07T22:05:19.000Z - 6 months ago

Cosmos Health files $200M mixed securities shelf

Cosmos Health initiates new nanotechnology research and development program

2025-10-31T14:50:30.000Z - 6 months ago

Cosmos Health initiates new nanotechnology research and development program

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Oct 31, 2025, 10:45 AM EDT - 6 months ago

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Cosmos Health acquires additional $200,000 of Ethereum

2025-10-21T16:15:42.000Z - 7 months ago

Cosmos Health acquires additional $200,000 of Ethereum

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Oct 21, 2025, 12:10 PM EDT - 7 months ago

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Cosmos Health regains compliance with Nasdaq minimum bid price requirement

2025-10-16T12:05:27.000Z - 7 months ago

Cosmos Health regains compliance with Nasdaq minimum bid price requirement

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Oct 13, 2025, 2:05 PM EDT - 7 months ago

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Oct 10, 2025, 8:00 AM EDT - 7 months ago

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Oct 3, 2025, 3:56 PM EDT - 7 months ago

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Sep 29, 2025, 8:00 AM EDT - 8 months ago

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Sep 25, 2025, 8:00 AM EDT - 8 months ago

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Sep 22, 2025, 8:00 AM EDT - 8 months ago

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Sep 11, 2025, 8:00 AM EDT - 8 months ago

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Aug 18, 2025, 12:45 PM EDT - 9 months ago

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Aug 12, 2025, 9:50 AM EDT - 9 months ago

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Aug 6, 2025, 9:20 AM EDT - 9 months ago

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Jun 24, 2025, 10:55 AM EDT - 11 months ago

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 2:30 PM EDT - 1 year ago

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 9:30 AM EDT - 1 year ago

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

May 7, 2025, 2:30 PM EDT - 1 year ago

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

May 6, 2025, 1:40 PM EDT - 1 year ago

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Apr 30, 2025, 12:50 PM EDT - 1 year ago

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Apr 16, 2025, 12:45 PM EDT - 1 year ago

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Apr 9, 2025, 1:40 PM EDT - 1 year ago

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Stopcryin
Stopcryin May. 13 at 11:59 AM
$COSM $0.32 ... here comes the $1 needed to get back in compliance with Nasdaq.
0 · Reply
walfofwallstreet
walfofwallstreet May. 13 at 11:12 AM
$COSM 👇🗞️💎👀👀👀👀👀🐺 Withdraws Registration Offering
0 · Reply
Stopcryin
Stopcryin May. 13 at 10:33 AM
$COSM ... or not! 😬😬
0 · Reply
Stopcryin
Stopcryin May. 13 at 10:32 AM
$COSM This is not aging well ... they never do 😉
0 · Reply
Stopcryin
Stopcryin May. 13 at 10:30 AM
$COSM This didn't age so well 😆
0 · Reply
Skoufa
Skoufa May. 13 at 8:15 AM
$COSM 15x from here
0 · Reply
Skoufa
Skoufa May. 13 at 8:15 AM
$COSM
0 · Reply
SuperShlongCapital
SuperShlongCapital May. 13 at 3:28 AM
$COSM This will likely cross $2 within 1 week. Tiny tiny float.
0 · Reply
ace6th
ace6th May. 13 at 1:35 AM
$COSM looking for .60s short term
0 · Reply
ace6th
ace6th May. 13 at 1:33 AM
$COSM Extremely oversold, Eyes on it! Ignore the Nay Sayers
0 · Reply
StockAuthority
StockAuthority May. 12 at 11:23 PM
$COSM clear huge upside
0 · Reply
Stopcryin
Stopcryin May. 12 at 9:48 PM
$COSM Everyone knows what happened to the last $4.00 price target by those 2 brothers lol This latest $4.50 is even more of a joke! This won't even get back to the $1 needed (in a few weeks) to stay listed without a RS ... mark this post kids!
0 · Reply
Stopcryin
Stopcryin May. 12 at 9:38 PM
$COSM Just like StockAuthority, I see we have another angry Bag Holder on board. Hang in there for the final dagger ... the Reverse Split 😁
0 · Reply
ACES_
ACES_ May. 12 at 9:06 PM
$COSM Wow.. they have retards on this board too.. crazy..
2 · Reply
Stopcryin
Stopcryin May. 12 at 9:01 PM
$COSM Let's all welcome the newest Bag Holder.
0 · Reply
Stopcryin
Stopcryin May. 12 at 9:00 PM
$COSM For those without level 2 ... heavy sell orders compared to tiny buy orders here in AH.
0 · Reply
indepth1
indepth1 May. 12 at 8:53 PM
$COSM @StockAuthority Buy at $.31 on 5-12 based AI DD & T/A analysis. 🔑 Removing S-1 filing will be key to retest $.35 resistance. This point $.35 is also the 10 day & 50 day SMA lines. That move will cause 10 day line to cross above 50 day SMA line. Agree with DD 🔑 @StockAuthority T00 cheap . ✅️ This is a signal T/A pivot Buy signal on close above $.35 resistance before the 10-Q due on 5-20 IMO. Bottoming reversal when price stays above $.30 support on a closing basis = T/A. ✅️
1 · Reply
StockAuthority
StockAuthority May. 12 at 8:40 PM
$COSM buy buy buy
1 · Reply
ACES_
ACES_ May. 12 at 8:29 PM
$COSM got in early early today.. lFG
0 · Reply
Stopcryin
Stopcryin May. 12 at 8:13 PM
$COSM Someone just bought 50 shares at $0.3199 in AH ... that's 16 bucks! You can't make this crap up folks!
1 · Reply
Stopcryin
Stopcryin May. 12 at 7:39 PM
$COSM Once again, these never age well 😋
0 · Reply
Stopcryin
Stopcryin May. 12 at 7:38 PM
$COSM Hope is a terrible investment tool.
0 · Reply